Your browser doesn't support javascript.
loading
Alterations of eicosanoids and related mediators in patients with schizophrenia.
Wang, Dongfang; Sun, Xiaoyu; Yan, Jingjing; Ren, Biao; Cao, Bing; Lu, Qingbin; Liu, Yaqiong; Zeng, Jing; Huang, Ninghua; Xie, Qing; Gu, Haiwei; Wang, Jingyu.
Afiliação
  • Wang D; Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China.
  • Sun X; Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China.
  • Yan J; Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China.
  • Ren B; Shimadzu (China) Co., LTD Beijing Branch, Beijing 100020, PR China.
  • Cao B; Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China.
  • Lu Q; Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China; Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, PR China; Peking University Medical and Health Analysis Center, Peking University, Beijing 100
  • Liu Y; Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China; Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, PR China; Peking University Medical and Health Analysis Center, Peking University, Beijing 100
  • Zeng J; Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China; Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, PR China; Peking University Medical and Health Analysis Center, Peking University, Beijing 100
  • Huang N; Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China; Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, PR China; Peking University Medical and Health Analysis Center, Peking University, Beijing 100
  • Xie Q; Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China; Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, PR China; Peking University Medical and Health Analysis Center, Peking University, Beijing 100
  • Gu H; Center for Metabolic and Vascular Biology, School of Nutrition and Health Promotion, College of Health Solutions, Arizona State University, Phoenix, AZ 85004, USA. Electronic address: haiweigu@asu.edu.
  • Wang J; Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China; Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, PR China; Peking University Medical and Health Analysis Center, Peking University, Beijing 100
J Psychiatr Res ; 102: 168-178, 2018 07.
Article em En | MEDLINE | ID: mdl-29674269

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Eicosanoides / Neurotransmissores Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Eicosanoides / Neurotransmissores Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article